← All Mutual Funds

BlackRock Health Sciences Trust

CIK: 0001314966 BME Equity
Report date: 2026-05-28
AUM $533M
Expense Ratio —
Category Equity
State DE
Fiscal Year End —
Inception Date —
Manager —
Latest Filing 2026-05-28

Holdings

From latest SEC N-PORT filing · US-listed stocks only

102 positions
# Security Name CUSIP Asset Type Weight % Value ($M) Quantity
1 ABT Abbott Laboratories Since 2026-07-07 002824100 Equity (Common)
2.30%
 $12.28 119,561
2 ABBV AbbVie Inc Since 2026-07-07 00287Y109 Equity (Common)
4.11%
 $21.91 100,720
3 A Agilent Technologies Inc Since 2026-07-07 00846U101 Equity (Common)
0.51%
 $2.72 23,884
4 AGIO Agios Pharmaceuticals Inc Since 2026-07-07 00847X104 Equity (Common)
0.19%
 $1.02 30,245
5 AKTS Aktis Oncology Inc Since 2026-07-07 01021M104 Equity (Common)
0.08%
 $0.42 23,229
6 ALLO Allogene Therapeutics Inc Since 2026-07-07 019770106 Equity (Common)
0.05%
 $0.26 105,465
7 ALNY Alnylam Pharmaceuticals Inc Since 2026-07-07 02043Q107 Equity (Common)
0.52%
 $2.77 8,378
8 ALMS Alumis Inc Since 2026-07-07 022307102 Equity (Common)
0.11%
 $0.57 25,795
9 COR Cencora Inc Since 2026-07-07 03073E105 Equity (Common)
0.94%
 $5.02 15,981
10 AMGN Amgen Inc Since 2026-07-07 031162100 Equity (Common)
3.43%
 $18.25 51,861
11 ELV Elevance Health Inc Since 2026-07-07 036752103 Equity (Common)
0.42%
 $2.26 7,713
12 APGE Apogee Therapeutics Inc Since 2026-07-07 03770N101 Equity (Common)
0.28%
 $1.50 17,780
13 ACLX Arcellx Inc Since 2026-07-07 03940C100 Equity (Common)
0.18%
 $0.94 8,208
14 RCUS Arcus Biosciences Inc Since 2026-07-07 03969F109 Equity (Common)
0.16%
 $0.86 39,654
15 BCAX Bicara Therapeutics Inc Since 2026-07-07 055477103 Equity (Common)
0.05%
 $0.28 14,144
16 BEAM Beam Therapeutics Inc Since 2026-07-07 07373V105 Equity (Common)
0.07%
 $0.35 14,611
17 BMRN BioMarin Pharmaceutical Inc Since 2026-07-07 09061G101 Equity (Common)
0.31%
 $1.67 29,577
18 BIIB Biogen Inc Since 2026-07-07 09062X103 Equity (Common)
1.10%
 $5.84 31,869
19 AZN AstraZeneca PLC Since 2026-07-07 — Equity (Common)
1.24%
 $6.62 33,842
20 BBOT BridgeBio Oncology Therapeutics Inc Since 2026-07-07 107924102 Equity (Common)
0.10%
 $0.54 60,030
21 BBIO Bridgebio Pharma Inc Since 2026-07-07 10806X102 Equity (Common)
0.25%
 $1.34 18,055
22 DRUG Bright Minds Biosciences Inc Since 2026-07-07 10919W405 Equity (Common)
0.11%
 $0.61 8,368
23 CGON CG oncology Inc Since 2026-07-07 156944100 Equity (Common)
0.06%
 $0.34 5,095
24 CRL Charles River Laboratories International Inc Since 2026-07-07 159864107 Equity (Common)
0.16%
 $0.85 4,936
25 COGT Cogent Biosciences Inc Since 2026-07-07 19240Q201 Equity (Common)
0.52%
 $2.77 72,020
26 CRVS Corvus Pharmaceuticals Inc Since 2026-07-07 221015100 Equity (Common)
0.03%
 $0.14 9,689
27 DNLI Denali Therapeutics Inc Since 2026-07-07 24823R105 Equity (Common)
0.08%
 $0.43 22,218
28 DXCM Dexcom Inc Since 2026-07-07 252131107 Equity (Common)
0.68%
 $3.64 57,910
29 DNTH Dianthus Therapeutics Inc Since 2026-07-07 252828108 Equity (Common)
0.26%
 $1.38 16,460
30 DYN Dyne Therapeutics Inc Since 2026-07-07 26818M108 Equity (Common)
0.08%
 $0.43 23,908
31 EWTX Edgewise Therapeutics Inc Since 2026-07-07 28036F105 Equity (Common)
0.13%
 $0.70 22,279
32 EIKN Eikon Therapeutics Inc Since 2026-07-07 282564103 Equity (Common)
0.13%
 $0.67 63,218
33 ENTA Enanta Pharmaceuticals Inc Since 2026-07-07 29251M106 Equity (Common)
0.10%
 $0.54 42,512
34 ERAS Erasca Inc Since 2026-07-07 29479A108 Equity (Common)
0.19%
 $1.01 62,282
35 EXEL Exelixis Inc Since 2026-07-07 30161Q104 Equity (Common)
0.16%
 $0.85 19,863
36 EYPT EyePoint Inc Since 2026-07-07 30233G209 Equity (Common)
0.04%
 $0.21 16,320
37 FDMT 4D Molecular Therapeutics Inc Since 2026-07-07 35104E100 Equity (Common)
0.02%
 $0.11 11,491
38 GILD Gilead Sciences Inc Since 2026-07-07 375558103 Equity (Common)
3.94%
 $20.97 150,487
39 GOSS Gossamer Bio Inc Since 2026-07-07 38341P102 Equity (Common)
0.00%
 $0.01 31,955
40 GH Guardant Health Inc Since 2026-07-07 40131M109 Equity (Common)
0.69%
 $3.68 39,876
41 HCA HCA Healthcare Inc Since 2026-07-07 40412C101 Equity (Common)
0.97%
 $5.18 10,937
42 HOLX Hologic Inc Since 2026-07-07 436440101 Equity (Common)
0.17%
 $0.92 12,193
43 HUM Humana Inc Since 2026-07-07 444859102 Equity (Common)
0.22%
 $1.17 6,765
44 IDXX IDEXX Laboratories Inc Since 2026-07-07 45168D104 Equity (Common)
0.71%
 $3.77 6,712
45 ILMN Illumina Inc Since 2026-07-07 452327109 Equity (Common)
0.31%
 $1.64 13,293
46 IMNM Immunome Inc Since 2026-07-07 45257U108 Equity (Common)
0.10%
 $0.55 25,340
47 NTLA Intellia Therapeutics Inc Since 2026-07-07 45826J105 Equity (Common)
0.11%
 $0.59 45,705
48 ISRG Intuitive Surgical Inc Since 2026-07-07 46120E602 Equity (Common)
2.38%
 $12.68 27,505
49 IONS Ionis Pharmaceuticals Inc Since 2026-07-07 462222100 Equity (Common)
0.21%
 $1.12 14,983
50 IQV IQVIA Holdings Inc Since 2026-07-07 46266C105 Equity (Common)
0.40%
 $2.13 12,502
51 JNJ Johnson & Johnson Since 2026-07-07 478160104 Equity (Common)
10.75%
 $57.27 234,293
52 KALV KalVista Pharmaceuticals Inc Since 2026-07-07 483497103 Equity (Common)
0.07%
 $0.38 18,705
53 KOD Kodiak Sciences Inc Since 2026-07-07 50015M109 Equity (Common)
0.11%
 $0.57 14,972
54 KYMR Kymera Therapeutics Inc Since 2026-07-07 501575104 Equity (Common)
0.07%
 $0.39 4,712
55 LBRX LB Pharmaceuticals Inc Since 2026-07-07 50180M108 Equity (Common)
0.22%
 $1.19 48,308
56 MBX MBX Biosciences Inc Since 2026-07-07 55287L101 Equity (Common)
0.16%
 $0.85 28,457
57 MAZE Maze Therapeutics Inc Since 2026-07-07 578784100 Equity (Common)
0.09%
 $0.48 15,965
58 MDLN Medline Inc Since 2026-07-07 58507V107 Equity (Common)
0.59%
 $3.14 70,645
59 MRK Merck & Co Inc Since 2026-07-07 58933Y105 Equity (Common)
5.36%
 $28.55 237,354
60 MTD Mettler-Toledo International Inc Since 2026-07-07 592688105 Equity (Common)
0.09%
 $0.50 395
61 MRNA Moderna Inc Since 2026-07-07 60770K107 Equity (Common)
0.47%
 $2.48 48,852
62 GLUE Monte Rosa Therapeutics Inc Since 2026-07-07 61225M102 Equity (Common)
0.09%
 $0.46 27,954
63 MLTX MoonLake Immunotherapeutics Since 2026-07-07 61559X104 Equity (Common)
0.02%
 $0.11 5,908
64 NTRA Natera Inc Since 2026-07-07 632307104 Equity (Common)
0.44%
 $2.36 11,821
65 NBIX Neurocrine Biosciences Inc Since 2026-07-07 64125C109 Equity (Common)
0.17%
 $0.90 6,793
66 NVS Novartis AG Since 2026-07-07 66987V109 Equity (Common)
0.63%
 $3.33 21,810
67 NUVL Nuvalent Inc Since 2026-07-07 670703107 Equity (Common)
0.55%
 $2.93 28,618
68 OCUL Ocular Therapeutix Inc Since 2026-07-07 67576A100 Equity (Common)
0.04%
 $0.19 22,645
69 OBIO Orchestra BioMed Holdings Inc Since 2026-07-07 68572M106 Equity (Common)
0.01%
 $0.07 17,635
70 ORKA Oruka Therapeutics Inc Since 2026-07-07 687604108 Equity (Common)
0.15%
 $0.78 15,986
71 PTCT PTC Therapeutics Inc Since 2026-07-07 69366J200 Equity (Common)
0.06%
 $0.29 4,329
72 PVLA Palvella Therapeutics Inc Since 2026-07-07 697947109 Equity (Common)
0.10%
 $0.56 4,480
73 PEN Penumbra Inc Since 2026-07-07 70975L107 Equity (Common)
0.72%
 $3.81 11,606
74 PFE Pfizer Inc Since 2026-07-07 717081103 Equity (Common)
2.75%
 $14.66 522,250
75 PTGX Protagonist Therapeutics Inc Since 2026-07-07 74366E102 Equity (Common)
0.63%
 $3.38 32,058
76 RDNT RadNet Inc Since 2026-07-07 750491102 Equity (Common)
0.10%
 $0.53 9,485
77 REGN Regeneron Pharmaceuticals Inc Since 2026-07-07 75886F107 Equity (Common)
1.12%
 $5.96 7,712
78 RGNX REGENXBIO Inc Since 2026-07-07 75901B107 Equity (Common)
0.03%
 $0.15 18,415
79 RVMD Revolution Medicines Inc Since 2026-07-07 76155X100 Equity (Common)
0.49%
 $2.58 26,560
80 RYTM Rhythm Pharmaceuticals Inc Since 2026-07-07 76243J105 Equity (Common)
0.76%
 $4.07 46,799
81 STOK Stoke Therapeutics Inc Since 2026-07-07 86150R107 Equity (Common)
0.25%
 $1.34 41,095
82 SMMT Summit Therapeutics Inc Since 2026-07-07 86627T108 Equity (Common)
0.29%
 $1.52 80,150
83 SNDX Syndax Pharmaceuticals Inc Since 2026-07-07 87164F105 Equity (Common)
0.02%
 $0.12 5,165
84 TERN Terns Pharmaceuticals Inc Since 2026-07-07 880881107 Equity (Common)
0.32%
 $1.70 32,290
85 TMO Thermo Fisher Scientific Inc Since 2026-07-07 883556102 Equity (Common)
1.76%
 $9.40 19,123
86 TCRX TScan Therapeutics Inc Since 2026-07-07 89854M101 Equity (Common)
0.01%
 $0.05 48,273
87 UPB Upstream Bio Inc Since 2026-07-07 91678A107 Equity (Common)
0.05%
 $0.27 30,052
88 PCVX Vaxcyte Inc Since 2026-07-07 92243G108 Equity (Common)
0.08%
 $0.44 7,541
89 VEEV Veeva Systems Inc Since 2026-07-07 922475108 Equity (Common)
0.29%
 $1.53 8,702
90 VKTX Viking Therapeutics Inc Since 2026-07-07 92686J106 Equity (Common)
0.23%
 $1.20 36,985
91 VRDN Viridian Therapeutics Inc Since 2026-07-07 92790C104 Equity (Common)
0.17%
 $0.88 45,005
92 VOR Vor BioPharma Inc Since 2026-07-07 929033207 Equity (Common)
0.03%
 $0.18 10,020
93 VYGR Voyager Therapeutics Inc Since 2026-07-07 92915B106 Equity (Common)
0.02%
 $0.12 31,420
94 WST West Pharmaceutical Services Inc Since 2026-07-07 955306105 Equity (Common)
0.25%
 $1.33 5,328
95 BBOT BRIDGEBIO ONCOLOGY THERAPEUTICS INC Since 2026-07-07 — Equity (Common)
0.03%
 $0.14 15,582
96 KLRA KAILERA THERAPEUTICS INC Since 2026-07-07 — Equity (Common)
0.09%
 $0.50 36,000
97 NYXH Nyxoah SA Since 2026-07-07 — Equity (Common)
0.02%
 $0.09 29,659
98 BHVN Biohaven Ltd Since 2026-07-07 — Equity (Common)
0.05%
 $0.26 30,469
99 MDT Medtronic PLC Since 2026-07-07 — Equity (Common)
1.25%
 $6.68 77,050
100 ROIV Roivant Sciences Ltd Since 2026-07-07 — Equity (Common)
0.21%
 $1.14 41,221
101 STE STERIS PLC Since 2026-07-07 — Equity (Common)
0.24%
 $1.30 5,880
102 WVE WaVe Life Sciences Ltd Since 2026-07-07 — Equity (Common)
0.04%
 $0.22 30,090
Frequently Asked Questions — BlackRock Health Sciences Trust
What type of mutual fund is BlackRock Health Sciences Trust?
BlackRock Health Sciences Trust is a SEC-registered Equity fund, with $533M in assets under management. Equity funds invest primarily in a diversified portfolio of stocks and equities, aiming for long-term capital appreciation. They carry higher market risk than bond or money market funds but historically offer stronger long-term returns. Equity mutual funds can be further classified as large-cap, mid-cap, small-cap, growth, value, or sector-specific depending on their investment mandate. As of its latest SEC N-PORT filing, BlackRock Health Sciences Trust holds 102 portfolio positions, all detailed in the holdings table on this page.
What are BlackRock Health Sciences Trust's assets under management (AUM)?
BlackRock Health Sciences Trust has $533M in assets under management (AUM) according to its most recent SEC N-PORT filing on StockSifting. AUM represents the total market value of all securities and other assets held by the fund as of the report date. A larger AUM generally signals a more established fund with greater institutional adoption, more trading liquidity, and potentially lower per-unit operational costs due to economies of scale. AUM changes daily as market prices fluctuate and as investors purchase or redeem fund shares — the figure shown here reflects the most recently available N-PORT disclosure, not the current real-time value. For the live figure, consult the fund's official website or its latest SEC EDGAR filing.
What are BlackRock Health Sciences Trust's top holdings?
According to BlackRock Health Sciences Trust's most recent SEC N-PORT filing, the fund's largest holdings by portfolio weight include Abbott Laboratories, AbbVie Inc, Agilent Technologies Inc , among others. The complete list of all 102 holdings — including CUSIP, asset type, portfolio weight percentage, dollar value, and share quantity — is available in the holdings table above. Holdings data is sourced directly from SEC EDGAR N-PORT filings and reflects the fund's positions as of the report date shown at the top of this page. Due to the 60-day SEC disclosure lag, these positions may differ from the fund's current portfolio. For the latest holdings before public release, refer to SEC EDGAR directly.
What is BlackRock Health Sciences Trust's expense ratio?
Expense ratio data for BlackRock Health Sciences Trust is not currently available in StockSifting's database. The expense ratio is the annual fee charged by a mutual fund as a percentage of your investment, covering management fees and operational costs. It is one of the most important factors affecting net long-term returns — lower expense ratios allow more of a fund's gross performance to flow through to investors. For the most accurate and current expense ratio, refer to the fund's official prospectus or its SEC EDGAR filings. You can also contact us if you believe this data should be present.
Where can I find BlackRock Health Sciences Trust's SEC filings?
BlackRock Health Sciences Trust is required to file monthly portfolio reports (Form N-PORT) with the U.S. Securities and Exchange Commission (SEC). Its SEC Central Index Key (CIK) is 0001314966. You can access all of BlackRock Health Sciences Trust's SEC filings — including N-PORT holdings disclosures, annual reports (Form N-CEN), and registration statements — directly on SEC EDGAR (CIK: 0001314966). N-PORT filings disclose the fund's complete portfolio holdings, fair value measurements, and certain risk metrics as of each filing period end date. StockSifting automatically parses these filings to populate the holdings table, AUM figures, and expense ratio displayed on this page, making the raw EDGAR data accessible without needing to download and parse XML files manually.
How current is BlackRock Health Sciences Trust's holdings data on StockSifting?
Holdings data for BlackRock Health Sciences Trust on StockSifting is sourced from its most recent SEC EDGAR N-PORT filing. Under SEC rules, registered investment companies must file N-PORT reports monthly, but these are made publicly available approximately 60 days after the reporting period end date. This means the holdings shown on this page reflect the fund's portfolio from roughly two months prior — not today's exact positions. The Report date displayed at the top of this page indicates exactly when the underlying data was current. If the fund has made significant portfolio changes since that date — responding to market events, earnings releases, or macro shifts — those changes will not be reflected here until the next N-PORT filing is released. For the most up-to-date holdings before the public disclosure window, refer to the fund's official website or SEC EDGAR directly. StockSifting is best used for fundamental research and historical portfolio analysis, not real-time trading decisions.